XYLAPAN, 20 mg/ml ενέσιμο διάλυμα για ιπποειδή, βοοειδή, σκύλους και γάτες
XYLAPAN, 20 mg/ml ενέσιμο διάλυμα για ιπποειδή, βοοειδή, σκύλους και γάτες
Authorised
- Xylazine hydrochloride
Product identification
Medicine name:
XYLAPAN, 20 mg/ml ενέσιμο διάλυμα για ιπποειδή, βοοειδή, σκύλους και γάτες
Active substance:
- Xylazine hydrochloride
Target species:
-
Horse
-
Cattle
-
Dog
-
Cat
Route of administration:
-
Intravenous use
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Xylazine hydrochloride20.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intravenous use
- Horse
-
Meat and offal3day
-
-
Intramuscular use
- Cattle
-
Meat and offal, milk3day
-
- Dog
- Cat
-
Subcutaneous use
- Cattle
- Horse
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- VETOQUINOL SA
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetoquinol Biowet Sp. z o.o.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 51834/13-07-2012/K-0114001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
